G. Verleden (Leuven, Belgium), J. Lordan (Newcastle-Upon-Tyne, United Kingdom)
Lung function improvement after hematopoetic stem cell transplantation A. Skrahin, A. Smirnou, A. Astrauko, A. Skrahina, V. Zmatchinski (Minsk, Belarus)
|  |
Specialized pulmonary rehabilitation in transplant recipients more than one year after surgery K. Kenn, B. Sczepanski (Schoenau, Germany)
|   |
Sixteen years‘ experience of lymphoproliferative disease following lung transplantation S. Bianchi, F. Black, G. Parry, K. Gould, A. Fisher, J. Lordan, J. Dark, P. Corris (Newcastle, United Kingdom)
|  |
Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation G. Verleden, Y. Lievens, L. Dupont, B. Vanaudenaerde, R. Vos, D. Van Raemdonck (Leuven, Belgium)
|  |
Lung cancer after lung transplantation A. M. Hamid, F. Gonin, D. Grenet, E. Longchampt, S. Friard, P. Bonnette, C. Picard, M. Stern (Suresnes, France)
|   |
Effects of cyclosporine A on airway mucociliary clearance in rats R. Pazetti, P. M. Pêgo-Fernandes, O. Tavares Ranzani, E. R. Parra, G. Lorenzi-Filho, F. Biscegli Jatene (São Paulo, Brazil)
|   |
Effects of bronchial transection and cyclosporine A on mucociliary transport in rats R. Pazetti, P. M. Pêgo-Fernandes, G. Lorenzi-Filho, P. H. Nascimento Saldiva, F. Biscegli Jatene (São Paulo, Brazil)
|   |
Effects of azathioprine on mucociliary clearance after bronchial section in a rat model R. Pazetti, P. M. Pêgo-Fernandes, M. Manzano Said, L. F. Pinho-Moreira, F. Biscegli Jatene (São Paulo, Campinas, Sao Paulo, Brazil)
|  |
Vibration response imaging (VRI) in lung transplant patients M. Kramer, A. Amital, A. Shteinmatz, D. Shitrit (Petach Tiqwa, Israel)
|  |
LAM, sarcoidosis, histiocytosis X – rare indications for lung transplantation – a single center experience M. A. R. Hoda, P. Jaksch, G. Lang, S. Taghavi, C. Aigner, M. Keplinger, W. Klepetko (Vienna, Austria)
|  |
The different manifestation of tuberculosis following allogenic kidney transplantation – report of two cases G. Przybylski, J. Czerniak, A. Jarzemska, Z. Wlodarczyk, A. Adamowicz, A. Gadzinska (Bydgoszcz, Poland)
|   |
Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients P. Seba, S. Irani, C. Schmid-Mahler, T. Kurowski, R. Speich, A. Boehler (Zurich, Switzerland)
|  |
A six year old lung transplanted boy with an EBV-associated bronchitis T. Eiwegger, E. Nachbaur, P. Jaksch, I. Eichler, W. Klepetko, Z. Szépfalusi, T. Frischer (Vienna, Austria)
|  |
Fourth lung transplantation for bronchiolitis obliterans in a patient with cystic fibrosis A. C. Metivier, V. Rosner, S. Weissrock, R. Kessler, G. Massard (France)
|   |
Mycobacterium abscessus infection in lung transplant patients: review of our series P. Morales, J. A. Ros, M. Blanes, V. Saiz, D. Pérez-Enguix, M. Santos (Valencia, Murcia, Spain)
|   |
Nutritional depletion, zinc and folic acid status in patients accepted for lung transplantation L. Forli, O. Bjortuft, J. Boe (Oslo, Norway)
|   |